We'd like your feedback
Your feedback is important to us. It will help us improve the quality of the study information on this site. Please answer both questions.
Contact the study team using the details below to take part. If there are no contact details below please ask your doctor in the first instance.
Mr
Clement
Orczyk
c.orczyk@ucl.ac.uk
NCITA
CTU
ncita.trials@ucl.ac.uk
Mr
Charlie
Mizon
Charlie.mizon@ucl.ac.uk
Malignant neoplasms of male genital organs
This information is provided directly by researchers, and we recognise that it isn't always easy to understand. We are working with researchers to improve the accessibility of this information. In some summaries, you may come across links to external websites. These websites will have more information to help you better understand the study.
This study seeks to analyse MRI images and biological samples from 60 men diagnosed as having intermediate risk prostate cancer at baseline and one year afterwards to compare the molecular, genetic and transcriptomic differences between cancers that progress and cancers which do not.
Start dates may differ between countries and research sites. The research team are responsible for keeping the information up-to-date.
The recruitment start and end dates are as follows:
Observational type: Cohort study;
You can take part if:
You may not be able to take part if:
• Any contraindication to MRI scans (e.g. metal implants, unmanageable claustrophobia). • Presence of a pacemaker. • Presence of a hip replacement. • Any hormonal treatment or inhibitors of 5 alpha-reductase in the previous 6 months. • Any previous TURP or other prostate surgery. • Previous treatment for prostate cancer. • Patients who have previously had sepsis due to a prostate biopsy. • Patients receiving concomitant treatment for their cancer. • Inability to provide full informed consent (e.g. due to dementia).
Below are the locations for where you can take part in the trial. Please note that not all sites may be open.
Mr
Clement
Orczyk
c.orczyk@ucl.ac.uk
NCITA
CTU
ncita.trials@ucl.ac.uk
Mr
Charlie
Mizon
Charlie.mizon@ucl.ac.uk
The study is sponsored by University College London and funded by The Jon Moulton Charity Trust (Guernsey) .
Your feedback is important to us. It will help us improve the quality of the study information on this site. Please answer both questions.
Read full details
for Trial ID: CPMS 45125
You can print or share the study information with your GP/healthcare provider or contact the research team directly.
